Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease modelSimone Reynolds, Michael F. Good, Rukshan Ahamed Mohamed Rafeek et al.|npj Vaccines|2023Cited by 19
A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteersVanessa Meier‐Stephenson, Maryna Yaskina, Jessica Dooley et al.|Trials|2024Cited by 12
Parenteral Vaccination with a Super Immunogen Targeting M-Protein Provides Unprecedented Protection Against Group A Streptococcus (StrepA) Respiratory InfectionsVictoria Ozberk, Manisha Pandey, Christie Short et al.|Unknown|2025Cited by 0
Delineating Humoral and Cellular Immune Responses Induced by a Peptide-Based Vaccine for Protection Against Streptococcus pyogenesDespena Vedis, Manisha Pandey, Ailin Lepletier et al.|Unknown|2025Cited by 0
Phase I Trial of a Peptide-Based Vaccine to Prevent Group A Streptococcal InfectionMichael F. Good, Michael Houghton, Manisha Pandey et al.|Unknown|2025Cited by 0